Does CLOBETASOL Cause Interstitial lung disease? 8 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Interstitial lung disease have been filed in association with CLOBETASOL (CLOBETASOL PROPIONATE). This represents 0.1% of all adverse event reports for CLOBETASOL.
8
Reports of Interstitial lung disease with CLOBETASOL
0.1%
of all CLOBETASOL reports
0
Deaths
6
Hospitalizations
How Dangerous Is Interstitial lung disease From CLOBETASOL?
Of the 8 reports, 6 (75.0%) required hospitalization, and 1 (12.5%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for CLOBETASOL. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does CLOBETASOL Cause?
Drug ineffective (3,217)
Psoriasis (1,317)
Product use in unapproved indication (706)
Pruritus (697)
Therapeutic product effect incomplete (643)
Skin exfoliation (550)
Off label use (540)
Treatment failure (535)
Erythema (464)
Arthralgia (417)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which CLOBETASOL Alternatives Have Lower Interstitial lung disease Risk?
CLOBETASOL vs CLOBETASONE
CLOBETASOL vs CLODRONATE
CLOBETASOL vs CLOFARABINE
CLOBETASOL vs CLOFAZIMINE
CLOBETASOL vs CLOMETHIAZOLE